Cases & Deals

  • Home
  • Practices
  • Rosetta Inpharmatics establishes patent portfolio for expression profiling, genomics, and bioinformatics

Share

Rosetta Inpharmatics establishes patent portfolio for expression profiling, genomics, and bioinformatics

February 2008

Client(s) Rosetta Inpharmatics, Inc.

On behalf of Rosetta Inpharmatics LLC (a wholly owned subsidiary of Merck & Co., Inc.), Jones Day prosecuted and assisted with the management of its patent portfolio relating to expression profiling, genomics, and bioinformatics.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.